India Sleep Apnea Devices Market, By Type (Therapeutic Devices and Diagnostic Devices), By Indication Type (Obstructive Sleep Apnea, Central Sleep Apnea), By End User (Hospitals & Clinics, Homecare), by Region, and Competition, Opportunity and Forecast, 2020-2030F

Market Overview

India Sleep Apnea Devices Market was valued at USD 147.02 million in 2024 and is anticipated to reach USD 223.51 Million by 2030, with a CAGR of 7.19% during 2025-2030. 

Sleep apnea devices are essential medical tools used to diagnose, treat, and manage sleep apnea a disorder marked by repeated breathing interruptions during sleep. These devices improve sleep quality, reduce associated health risks, and enhance overall well-being. Common solutions include oral appliances such as mandibular advancement devices (MADs) and tongue retaining devices (TRDs), which help keep airways open in mild to moderate cases. Positional therapy devices support better sleep posture, while supplemental oxygen may be used in severe cases to maintain adequate oxygen levels.

Rising awareness about the health risks of untreated sleep apnea is encouraging more individuals to seek timely diagnosis and treatment. Technological advancements such as quieter machines, improved mask comfort, and advanced data tracking are enhancing usability and patient compliance. Additionally, India’s aging population, which is more prone to sleep apnea, is driving demand. Increasing disposable incomes and higher healthcare spending are further supporting the adoption of sleep apnea devices across the country.

Key Market Drivers

Advancements in Device Technology

Technological advancements in CPAP and BiPAP therapy are materially improving sleep apnea management in India, where an AIIMS led meta analysis found that about 104 million working age Indians may have obstructive sleep apnea and roughly 47 million may have moderate to severe disease, creating a strong need for devices that are easier to use consistently at home.

The newest systems are improving comfort through auto adjusting pressure delivery, as ResMed’s AirSense 11 changes airflow on a breath by breath basis and is designed to deliver the user’s ideal lowest therapy pressure as needs vary over time, while Philips DreamStation 2 offers a pressure range of 4 to 20 cm H2O with Flex pressure relief and Ramp Plus settings to ease therapy initiation.

Adherence is also improving because modern devices now support digital coaching and remote care, with AirSense 11 using Personal Therapy Assistant, Care Check In during the first 28 days, and remote monitoring through AirView, while DreamStation 2 includes an integrated cell modem and Bluetooth connectivity. Convenience has become a real adoption lever as well, since Philips lists DreamStation 2 at 1040 grams without the power supply and water tank, and also equips it with an integrated humidifier with 325 ml capacity, adaptive humidification, five settings, and compatibility with heated tubing, all of which help make therapy more travel friendly and comfortable.

For instance, ResMed’s India platform positions AirSense 11 within a broader ecosystem that combines the device with AirFit and AirTouch masks plus the myAir app, showing how leading companies are no longer selling only airflow machines but a connected therapy experience built around comfort, leak management, remote follow up, and stronger long term compliance.

Growing Awareness

Rising awareness of sleep apnea is becoming a strong demand driver for sleep apnea devices in India because more patients now recognize warning signs such as loud snoring, daytime fatigue, poor concentration, and interrupted breathing, and this is pushing more people toward formal diagnosis and treatment after understanding the condition’s links with hypertension, cardiovascular disease, stroke, and type 2 diabetes.

The scale of the need is substantial, as an AIIMS led meta analysis estimated that about 104 million working age Indians may have obstructive sleep apnea and around 47 million may have moderate to severe disease, which is encouraging physicians, sleep specialists, and hospitals to increase referrals for sleep studies and device based therapy. Awareness is also being strengthened through digital education, public campaigns, and clinician outreach led by major industry participants, with ResMed stating that it has been raising awareness in India since 2009 through health conferences, consumer campaigns, and partnerships with distributors to educate patients, doctors, and public health stakeholders.

For instance, ResMed’s 2024 Obstructive Sleep Apnea Symposium initiative was rolled out across Indian metros including Delhi, Kolkata, and Hyderabad and had already involved more than 250 leading sleep specialists, showing how structured professional education and broader public messaging are helping convert awareness into diagnosis, referrals, and greater adoption of CPAP and related sleep apnea devices in India.

Increasing Aging Population

The rising elderly population in India is a key driver of demand for sleep apnea devices. Sleep apnea is more prevalent among older adults due to age-related factors such as reduced muscle tone in the upper airway, weight gain, and a higher likelihood of chronic conditions like hypertension, diabetes, and cardiovascular diseases. These factors increase the risk and severity of sleep apnea, making device-based treatment essential.

Age-related airway collapse and declining physiological function further heighten the need for continuous airway support during sleep. Symptoms such as daytime fatigue and reduced cognitive function also encourage older individuals to seek diagnosis and treatment to improve quality of life. Routine medical check-ups in older age often lead to earlier detection and increased adoption of sleep apnea devices.

Additionally, growing awareness among the elderly and better access to health insurance coverage make diagnosis and treatment more accessible. Since sleep apnea requires long-term management, this demographic generates sustained demand for devices, significantly contributing to the growth of the India sleep apnea devices market.

Download Free Sample Report

Key Market Challenges

Compliance and Comfort

Despite their effectiveness, sleep apnea devices especially Continuous Positive Airway Pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) machines, face challenges related to user comfort and compliance. Many users find wearing masks and tubing uncomfortable or disruptive, particularly during the initial adjustment phase, which can impact consistent usage.

Achieving a proper mask fit is another key issue. Poorly fitting masks can cause air leaks, reducing treatment effectiveness and leading to discomfort. Similarly, adapting to prescribed air pressure levels can be difficult higher pressures may feel uncomfortable, while lower settings may not adequately manage apnea events, requiring careful calibration.

Noise from certain devices can also disturb both users and their partners, affecting sleep quality. Additionally, some individuals experience claustrophobia when using masks, leading to resistance or discontinuation of therapy. Although manufacturers are introducing quieter machines and more ergonomic, less restrictive mask designs, overcoming these comfort-related barriers remains essential to improving patient adherence and treatment outcomes.

Stigma and Denial

Stigma and denial remain significant barriers to the diagnosis and treatment of sleep apnea in India. Many individuals fail to recognize common symptoms such as loud snoring, gasping during sleep, and persistent daytime fatigue, leading to low awareness and delayed medical intervention. Fear of being judged or labeled for having a sleep disorder often discourages people from discussing symptoms with healthcare professionals.

Misconceptions further reinforce this issue, with some perceiving sleep apnea as a sign of poor lifestyle habits or weakness. This mindset prevents individuals from acknowledging the condition and seeking timely care. Stigma also extends to the use of devices like Continuous Positive Airway Pressure (CPAP) machines, which some users find embarrassing or intrusive, affecting their willingness to adopt treatment.

Concerns about personal relationships and social acceptance can also deter individuals from addressing the condition. Additionally, cultural norms and societal attitudes in India may contribute to underreporting and hesitation, ultimately limiting the adoption of sleep apnea devices and delaying effective management.

Key Market Trends

Home Sleep Testing

Home Sleep Testing allows individuals to undergo sleep apnea testing in the comfort of their own homes. This convenience and accessibility make it easier for more people to access sleep apnea diagnosis, particularly in regions where access to sleep centers may be limited. HST is often more cost-effective than in-lab polysomnography (PSG), which is a traditional sleep study conducted in a clinical setting.

The lower cost of HST makes it a more attractive option for individuals seeking a diagnosis. Many individuals find it more comfortable to sleep in their own beds, which can lead to more accurate test results. HST minimizes the disruption to an individual's sleep patterns compared to spending a night in a sleep lab. Home sleep testing eliminates the need for travel and overnight stays at sleep centers, offering greater convenience for individuals who may have busy schedules or transportation challenges. The COVID-19 pandemic highlighted the importance of reducing in-person interactions, and HST became even more appealing during this time. It allowed for social distancing and minimized the risk of exposure to the virus.

HST is not only used for diagnosis but also for ongoing monitoring of sleep apnea treatment. Individuals can use HST devices to assess the effectiveness of their treatment, making it a valuable tool for long-term care. Many healthcare providers in India are increasingly accepting HST as a reliable method for diagnosing sleep apnea. They may recommend HST to their patients, further promoting its use.

Segmental Insights

Type Insights

In 2024, the India Sleep Apnea Devices Market largest share was held by Therapeutic Devices segment and is predicted to continue expanding over the coming years. Therapeutic devices are at the core of treating sleep apnea, which is a prevalent and serious sleep disorder. These devices are primarily designed to alleviate the symptoms and health risks associated with sleep apnea, making them a fundamental component of treatment.

Sleep apnea is a common condition in India and worldwide, with a significant number of individuals affected by it. As awareness of sleep apnea has increased, more individuals are being diagnosed and prescribed therapeutic devices as part of their treatment plan. The Therapeutic Devices segment encompasses various devices designed to treat sleep apnea, including Continuous Positive Airway Pressure (CPAP) machines, Bilevel Positive Airway Pressure (BiPAP) machines, adaptive servo-ventilation (ASV) devices, and others.

The availability of a wide range of devices allows healthcare providers to tailor treatments to the specific needs of patients. Therapeutic devices have been shown to be clinically effective in managing sleep apnea, improving patients' breathing patterns, reducing apnea events, and alleviating associated symptoms. This demonstrated effectiveness contributes to the growing adoption of these devices.

Indication Type Insights

In 2024, the India Sleep Apnea Devices Market largest share was held by Obstructive Sleep Apnea segment and is predicted to continue expanding over the coming years. Obstructive Sleep Apnea is the most common type of sleep apnea, both in India and globally. It is characterized by the repeated partial or complete blockage of the upper airway during sleep. OSA is more prevalent than central sleep apnea or complex sleep apnea syndrome, making it the dominant condition in this market.

OSA is widely recognized as a significant public health concern due to its association with various health issues, including cardiovascular problems, diabetes, and daytime fatigue. This awareness has led to more individuals seeking diagnosis and treatment for OSA, which in turn drives the demand for OSA-specific sleep apnea devices. Healthcare providers often place a strong emphasis on diagnosing OSA because of its potential health consequences. As a result, more patients undergo sleep studies and assessments for OSA, contributing to the need for OSA-specific devices.

The treatment of OSA often involves the use of Continuous Positive Airway Pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) devices, which are designed to alleviate the obstruction in the airway. These devices are the primary tools used to manage OSA, and they constitute a significant portion of the sleep apnea device market. Medical device manufacturers have invested in the development of advanced CPAP and BiPAP devices with features tailored to OSA patients. These innovations have enhanced patient comfort and compliance, driving the adoption of OSA-specific devices.

Download Sample Report

Regional Insights

The North India region dominates the India Sleep Apnea Devices Market in 2024. North India is home to several densely populated cities and states, including Delhi, Uttar Pradesh, and Haryana. The higher population density means there is a larger pool of potential patients with sleep apnea, driving the demand for sleep apnea devices. North India has experienced significant urbanization and lifestyle changes. Urban areas often have a higher prevalence of sleep disorders due to factors like stress, sedentary lifestyles, and dietary habits, which contribute to the demand for sleep apnea devices.

North India has relatively better healthcare infrastructure compared to some other regions in the country. This includes a higher concentration of hospitals, clinics, and sleep disorder centers where patients can access diagnosis and treatment for sleep apnea. North India has a relatively higher level of health awareness compared to some other regions. This results in more people seeking medical advice and diagnosis for sleep-related issues, which, in turn, drives the demand for sleep apnea devices.

Recent Developments

• In March 2025, Philips India launched its “Sleep Saviour” campaign with channel partners to widen access to sleep-therapy devices for obstructive sleep apnea patients across the country. The company said the program would extend reach through pharmacy chains and retail outlets, including in Tier 2 and Tier 3 cities, with the aim of improving access to therapy based on clinical guidance from healthcare providers. Although this was not a new hardware launch, it still counts as a meaningful collaboration in India’s sleep apnea devices space because it linked Philips with distribution partners to expand real-world device access beyond major metros.
• In January 2025, ResMed launched the AirSense 11 in India, positioning it as its next-generation CPAP device for people with obstructive sleep apnea who struggle to start and stay on therapy. The company said the device combines tailored digital features with the myAir patient engagement app and the AirView remote monitoring platform, allowing clinicians to monitor adherence and intervene earlier when therapy issues arise. This was a notable product launch for India because it brought a more connected, digitally managed sleep-apnea treatment platform into a market where adherence and long-term therapy use remain major barriers.

Key Market Players

• ResMed
• BPL Medical Technologies Pvt. Ltd.
• BMC Co.,Ltd.
• Koninklijke Philips N.V.
• Medical Depot, Inc.
• Fisher & Paykel Healthcare India Private Ltd
• Nihon Kohden Corporation
• Teleflex Medical Private Limited,
• Wipro GE Healthcare Pvt Ltd

Report Scope:

In this report, the India Sleep Apnea Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• India Sleep Apnea Devices Market, By Type:

o   Therapeutic Devices

o   Diagnostic Devices

•  India Sleep Apnea Devices Market, By Indication Type:

o   Obstructive Sleep Apnea

o   Central Sleep Apnea

• India Sleep Apnea Devices Market, By End User:

o   Hospitals & Clinics

o   Homecare

• India Sleep Apnea Devices Market, By Region:

o   North India

o   South India

o   East India

o   West India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the India Sleep Apnea Devices Market.

Available Customizations:

India Sleep Apnea Devices Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

India Sleep Apnea Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]